NOVOLOG Side Effects

6615275-8 | Carotid Artery Stenosis
on Feb 23, 2010 Male patient from UNITED STATES , weighting 214.0 lb, was diagnosed with type 1 diabetes mellitus, cardiac disorder, blood cholesterol increased, angina pectoris and was treated with Novolog (View Usage). Patient experienced the following unwanted or unexpected effects: carotid artery stenosis. Novolog dosage: 10 U, Tid Before Meals. During the same period patient was treated with PLAVIX (1 Tab, Qd) (View Plavix Review and Plavix Label ), LIPITOR (1 Tab, Qd) (View Lipitor Review and Lipitor Label ), NITROGLYCERIN (Unk) (View Nitroglycerin Review and Nitroglycerin Label ). Patient was hospitalized.

6609501-9 | Asthma, Back Pain, Blood Glucose Fluctuation, Chronic Obstructive Pulmonary Disease, Hypersensitivity, Muscle Spasms, Oedema Peripheral, Pneumonia
Patient was taking Novolog (View Usage). Patient had the following side effects: asthma (What is asthma?), back pain (What is back pain?), blood glucose fluctuation, chronic obstructive pulmonary disease, hypersensitivity, muscle spasms, oedema peripheral, pneumonia (What is pneumonia?) on Feb 18, 2010 from UNITED STATES Additional patient health information: Female patient , 47 years of age, was diagnosed with insulin-requiring type 2 diabetes mellitus and. Novolog dosage: Sliding Scale. During the same period patient was treated with LEVEMIR (View Levemir Review and Levemir Label ), ACTOS (View Actos Review and Actos Label ), ABILIFY (View Abilify Review and Abilify Label ), LEXAPRO (View Lexapro Review and Lexapro Label ). Patient was hospitalized.

6601167-7 | Cerebrovascular Accident
Adverse event was reported on Feb 17, 2010 by a Female patient taking Novolog (View Usage) (Dosage: 10 U Bf, 10 U Lunch, 8 U Dinner) was diagnosed with diabetes mellitus and. Location: UNITED STATES , weighting 190.0 lb, After Novolog was administered, patient had the following side effects: cerebrovascular accident. During the same period patient was treated with LANTUS (Unk) (View Lantus Review and Lantus Label ). Patient was hospitalized.

6595972-3 | Abdominal Pain Upper, Hiatus Hernia, Malaise
on Feb 12, 2010 Female patient from UNITED STATES , 80 years of age, was diagnosed with insulin-requiring type 2 diabetes mellitus and was treated with Novolog (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, hiatus hernia, malaise. Novolog dosage: Unk. During the same period patient was treated with LANTUS (28 Iu, Qd) (View Lantus Review and Lantus Label ). Patient was hospitalized.


6584884-7 | Convulsion, Dizziness, Dry Mouth, Dysarthria, Dyspnoea, Loss Of Consciousness, Oedema Mouth, Suicidal Ideation, Swelling Face
on Feb 08, 2010 Female patient from UNITED STATES , weighting 200.0 lb, was diagnosed with type 1 diabetes mellitus, muscle spasms, pain (What is pain?), nervousness, asthma (What is asthma?), gastrooesophageal reflux disease and was treated with Novolog (View Usage). Patient had the following side effects: convulsion, dizziness (What is dizziness?), dry mouth, dysarthria, dyspnoea, loss of consciousness, oedema mouth, suicidal ideation, swelling face. Novolog dosage: 25-35 Iu (6 Times Qd). During the same period patient was treated with LANTUS (130 Iu, Qd (at Bedtime)) (View Lantus Review and Lantus Label ), VALIUM (Unk) (View Valium Review and Valium Label ), PERCOCET (Unk) (View Percocet Review and Percocet Label ), XANAX (Unk) (View Xanax Review and Xanax Label ), SINGULAIR (Unk) (View Singulair Review and Singulair Label ), SYMBICORT (Unk) (View Symbicort Review and Symbicort Label ), FLONASE (Unk) (View Flonase Review and Flonase Label ), PROTONIX /01263201/ (Unk) (View Protonix /01263201/ Review and Protonix /01263201/ Label ).

6584618-6 | Hypoglycaemia, Product Substitution Issue
Patient was taking Novolog (View Usage). After Novolog was administered, patient had the following side effects: hypoglycaemia, product substitution issue on Feb 13, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 271.0 lb, was diagnosed with insulin-requiring type 2 diabetes mellitus and. Novolog dosage: 38 Units Am 45 Units Pm Bid Subcutaneous (057) Mid Dec 2009 To 02/09/2010.

6581209-8 | Blood Glucose Fluctuation, Heart Rate Irregular
Adverse event was reported on Feb 04, 2010 by a Male patient taking Novolog (View Usage) (Dosage: 15 Iu, Qd) was diagnosed with type 2 diabetes mellitus, chronic obstructive pulmonary disease and. Location: UNITED STATES , weighting 255.0 lb, Patient experienced the following unwanted or unexpected effects: blood glucose fluctuation, heart rate irregular. During the same period patient was treated with LEVEMIR (25 Iu, Qd) (View Levemir Review and Levemir Label ), CORTICOSTEROID NOS (Unk) (View Corticosteroid Nos Review and Corticosteroid Nos Label ). Patient was hospitalized.

6574972-3 | Hypoglycaemia, Sopor
on Jan 29, 2010 Male patient from ITALY , 57 years of age, was diagnosed with diabetes mellitus and was treated with Novolog (View Usage). Patient had the following side effects: hypoglycaemia, sopor. Novolog dosage: 41 Iu, Qd. During the same period patient was treated with LANTUS (24 Iu, Qd) (View Lantus Review and Lantus Label ), TRIATEC /00116401/ (View Triatec /00116401/ Review and Triatec /00116401/ Label ), REXTAT (View Rextat Review and Rextat Label ), ASPIRIN (100 Mg, Qd) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6574967-X | Hallucination, Visual, No Therapeutic Response
on Jan 29, 2010 Female patient from UNITED STATES , 81 years of age, weighting 165.0 lb, was diagnosed with insulin-requiring type 2 diabetes mellitus, hypertension and was treated with Novolog (View Usage). After Novolog was administered, patient had the following side effects: hallucination, visual, no therapeutic response. Novolog dosage: Sliding Scale 2-3 Iu, Tid With Meals. During the same period patient was treated with LANTUS (20 U, Qd At Hs) (View Lantus Review and Lantus Label ), COZAAR (Unk) (View Cozaar Review and Cozaar Label ), NORVASC (Unk) (View Norvasc Review and Norvasc Label ).

6571027-9 | Accidental Overdose, Blood Glucose Increased, Hypoglycaemia
Patient was taking Novolog (View Usage). Patient experienced the following unwanted or unexpected effects: accidental overdose, blood glucose increased, hypoglycaemia on Jan 27, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 173.0 lb, was diagnosed with type 1 diabetes mellitus, hypertension, restless legs syndrome, gastrooesophageal reflux disease, prostatic disorder and. Novolog dosage: Sliding Scale, Prn. During the same period patient was treated with DIOVAN /01319601/ (View Diovan /01319601/ Review and Diovan /01319601/ Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), AVODART (View Avodart Review and Avodart Label ).

6567828-3 | Transient Ischaemic Attack
Adverse event was reported on Oct 19, 2009 by a Male patient taking Novolog (View Usage) (Dosage: Sliding Scale) was diagnosed with insulin-requiring type 2 diabetes mellitus, depression (What is depression?), hypertension, cerebrovascular accident, cardiac disorder, sleep disorder (What is sleep disorder?), blood triglycerides increased and. Location: UNITED STATES , weighting 193.0 lb, Patient had the following side effects: transient ischaemic attack. During the same period patient was treated with LANTUS (45 Iu, Bid) (View Lantus Review and Lantus Label ), WELLBUTRIN (300 Mg, Qd) (View Wellbutrin Review and Wellbutrin Label ), COREG (25 Mg, Bid) (View Coreg Review and Coreg Label ), PLAVIX (75 Mg, Qd) (View Plavix Review and Plavix Label ), DIGOXIN (.125 Mg, Qd) (View Digoxin Review and Digoxin Label ), DOXEPIN HCL (25 Mg, Qd) (View Doxepin Hcl Review and Doxepin Hcl Label ), TRICOR (145 Mg, Qd) (View Tricor Review and Tricor Label ), FOLIC ACID (1 Mg, Qd) (View Folic Acid Review and Folic Acid Label ).

6567817-9 | Cerebrovascular Accident
on Oct 19, 2009 Male patient from UNITED STATES , weighting 193.0 lb, was diagnosed with insulin-requiring type 2 diabetes mellitus, depression (What is depression?), hypertension, cerebrovascular accident, cardiac disorder, sleep disorder (What is sleep disorder?), blood triglycerides increased and was treated with Novolog (View Usage). After Novolog was administered, patient had the following side effects: cerebrovascular accident. Novolog dosage: Unk, Unk. During the same period patient was treated with LANTUS (45 Iu, Bid) (View Lantus Review and Lantus Label ), WELLBUTRIN (300 Mg, Qd) (View Wellbutrin Review and Wellbutrin Label ), COREG (25 Mg, Bid) (View Coreg Review and Coreg Label ), PLAVIX (75 Mg, Qd) (View Plavix Review and Plavix Label ), DIGOXIN (.125 Mg, Qd) (View Digoxin Review and Digoxin Label ), DOXEPIN HCL (25 Mg, Qd) (View Doxepin Hcl Review and Doxepin Hcl Label ), TRICOR (145 Mg, Qd) (View Tricor Review and Tricor Label ), FOLIC ACID (1 Mg, Qd) (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6567800-3 | Intention Tremor
on Oct 19, 2009 Male patient from UNITED STATES , weighting 193.0 lb, was diagnosed with insulin-requiring type 2 diabetes mellitus, depression (What is depression?), hypertension, cerebrovascular accident, cardiac disorder, sleep disorder (What is sleep disorder?), blood triglycerides increased and was treated with Novolog (View Usage). Patient experienced the following unwanted or unexpected effects: intention tremor. Novolog dosage: Sliding Scale. During the same period patient was treated with LANTUS (45 Iu, Bid) (View Lantus Review and Lantus Label ), WELLBUTRIN (300 Mg, Qd) (View Wellbutrin Review and Wellbutrin Label ), COREG (25 Mg, Bid) (View Coreg Review and Coreg Label ), PLAVIX (75 Mg, Qd) (View Plavix Review and Plavix Label ), DIGOXIN (.125 Mg, Qd) (View Digoxin Review and Digoxin Label ), DOXEPIN HCL (25 Mg, Qd) (View Doxepin Hcl Review and Doxepin Hcl Label ), TRICOR (145 Mg, Qd) (View Tricor Review and Tricor Label ), FOLIC ACID (1 Mg, Qd) (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6567797-6 | Deafness Unilateral
Patient was taking Novolog (View Usage). Patient had the following side effects: deafness unilateral on Oct 19, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 193.0 lb, was diagnosed with insulin-requiring type 2 diabetes mellitus, depression (What is depression?), hypertension, cerebrovascular accident, cardiac disorder, sleep disorder (What is sleep disorder?), blood triglycerides increased and. Novolog dosage: Sliding Scale. During the same period patient was treated with LANTUS (45 Iu, Bid) (View Lantus Review and Lantus Label ), WELLBUTRIN (300 Mg, Qd) (View Wellbutrin Review and Wellbutrin Label ), COREG (25 Mg, Bid) (View Coreg Review and Coreg Label ), PLAVIX (75 Mg, Qd) (View Plavix Review and Plavix Label ), DIGOXIN (.125 Mg, Qd) (View Digoxin Review and Digoxin Label ), DOXEPIN HCL (25 Mg, Qd) (View Doxepin Hcl Review and Doxepin Hcl Label ), TRICOR (145 Mg, Qd) (View Tricor Review and Tricor Label ), FOLIC ACID (1 Mg, Qd) (View Folic Acid Review and Folic Acid Label ).

6567787-3 | Renal Failure Chronic
Adverse event was reported on Oct 19, 2009 by a Male patient taking Novolog (View Usage) (Dosage: Sliding Scale) was diagnosed with insulin-requiring type 2 diabetes mellitus, depression (What is depression?), hypertension, cerebrovascular accident, cardiac disorder, sleep disorder (What is sleep disorder?), blood triglycerides increased and. Location: UNITED STATES , weighting 193.0 lb, After Novolog was administered, patient had the following side effects: renal failure chronic. During the same period patient was treated with LANTUS (45 Iu, Bid) (View Lantus Review and Lantus Label ), WELLBUTRIN (300 Mg, Qd) (View Wellbutrin Review and Wellbutrin Label ), COREG (25 Mg, Bid) (View Coreg Review and Coreg Label ), PLAVIX (75 Mg, Qd) (View Plavix Review and Plavix Label ), DIGOXIN (.125 Mg, Qd) (View Digoxin Review and Digoxin Label ), DOXEPIN HCL (25 Mg, Qd) (View Doxepin Hcl Review and Doxepin Hcl Label ), TRICOR (145 Mg, Qd) (View Tricor Review and Tricor Label ), FOLIC ACID (1 Mg, Qd) (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6565355-0 | Cerebrovascular Accident
on Oct 19, 2009 Male patient from UNITED STATES , weighting 193.0 lb, was diagnosed with insulin-requiring type 2 diabetes mellitus, depression (What is depression?), hypertension, cardiac disorder, sleep disorder (What is sleep disorder?), blood triglycerides increased, cardiac failure congestive and was treated with Novolog (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident. Novolog dosage: Sliding Scale. During the same period patient was treated with LANTUS (45 Iu, Bid) (View Lantus Review and Lantus Label ), WELLBUTRIN (300 Mg, Qd) (View Wellbutrin Review and Wellbutrin Label ), COREG (25 Mg, Bid) (View Coreg Review and Coreg Label ), DIGOXIN (.125 Mg, Qd) (View Digoxin Review and Digoxin Label ), DOXEPIN HCL (25 Mg, Qd) (View Doxepin Hcl Review and Doxepin Hcl Label ), TRICOR (145 Mg, Qd) (View Tricor Review and Tricor Label ), FOLIC ACID (1 Mg, Qd) (View Folic Acid Review and Folic Acid Label ), LASIX (20 Mg, Bid) (View Lasix Review and Lasix Label ). Patient was hospitalized.

6557718-4 | Diabetic Ketoacidosis
on Jan 27, 2010 Male patient from UNITED STATES , weighting 71.99 lb, was diagnosed with type 1 diabetes mellitus, attention deficit/hyperactivity disorder and was treated with Novolog (View Usage). Patient had the following side effects: diabetic ketoacidosis. Novolog dosage: Unk , Unk. During the same period patient was treated with VYVANSE (Unk) (View Vyvanse Review and Vyvanse Label ). Patient was hospitalized.

6550349-1 | Amputation, Blood Glucose Increased, Cardiac Failure Congestive, Hypertension
Patient was taking Novolog (View Usage). After Novolog was administered, patient had the following side effects: amputation, blood glucose increased, cardiac failure congestive, hypertension on Jan 15, 2010 from UNITED STATES Additional patient health information: Female patient , 77 years of age, weighting 193.0 lb, was diagnosed with insulin-requiring type 2 diabetes mellitus and. Novolog dosage: 10 Iu, Tid (sliding Scale). During the same period patient was treated with LANTUS (40 Iu, Qd) (View Lantus Review and Lantus Label ). Patient was hospitalized.

6544357-4 | Blood Glucose Increased, Device Malfunction, Product Quality Issue
Adverse event was reported on Jan 20, 2010 by a Male patient taking Novolog (View Usage) (Dosage: Up To 30 Units Daily) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 59 years of age, Patient experienced the following unwanted or unexpected effects: blood glucose increased, device malfunction, product quality issue.

6543889-2 | Blood Glucose Increased, Dehydration
on Jan 13, 2010 Female patient from UNITED STATES , weighting 105.0 lb, was diagnosed with diabetes mellitus and was treated with Novolog (View Usage). Patient had the following side effects: blood glucose increased, dehydration. Novolog dosage: Unk.

6543139-7 | Abdominal Pain, Blood Glucose Decreased, Blood Glucose Increased, Blood Pressure Decreased, Cardiac Arrest, Device Breakage, Device Malfunction, Dizziness, Hyperhidrosis
on Jan 13, 2010 Male patient from UNITED STATES , weighting 218.0 lb, was diagnosed with type 2 diabetes mellitus, hypertension, asthma (What is asthma?) and was treated with Novolog (View Usage). After Novolog was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), blood glucose decreased, blood glucose increased, blood pressure decreased, cardiac arrest (What is cardiac arrest?), device breakage, device malfunction, dizziness (What is dizziness?), hyperhidrosis. Novolog dosage: 25 Iu, Qd. During the same period patient was treated with LEVEMIR (60 Iu, Bid (morning And Evening)) (View Levemir Review and Levemir Label ), LISINOPRIL (Unk) (View Lisinopril Review and Lisinopril Label ), FLOVENT (Unk) (View Flovent Review and Flovent Label ). Patient was hospitalized.

6541657-9 | Blood Glucose Increased, Blood Pressure Increased, Dehydration, Panic Attack
Patient was taking Novolog (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, blood pressure increased, dehydration, panic attack on Jan 13, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 185.0 lb, was diagnosed with insulin-requiring type 2 diabetes mellitus, blood pressure increased, blood cholesterol increased, anxiety (What is anxiety?) and. Novolog dosage: Sliding Scale. During the same period patient was treated with HYZAAR /01284801/ (Unk) (View Hyzaar /01284801/ Review and Hyzaar /01284801/ Label ), TIAZAC /00489702/ (Unk) (View Tiazac /00489702/ Review and Tiazac /00489702/ Label ), CRESTOR (Unk) (View Crestor Review and Crestor Label ), LANTUS (50 Iu, Qd (pm)) (View Lantus Review and Lantus Label ), ESTRATEST (Unk) (View Estratest Review and Estratest Label ), PROZAC /00724401/ (Unk) (View Prozac /00724401/ Review and Prozac /00724401/ Label ).

6537390-X | Dehydration, Dizziness, Pain In Extremity, Presyncope, Product Quality Issue
Adverse event was reported on Jan 07, 2010 by a Female patient taking Novolog (View Usage) (Dosage: Unk) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 54 years of age, weighting 164.0 lb, Patient had the following side effects: dehydration, dizziness (What is dizziness?), pain in extremity, presyncope, product quality issue. During the same period patient was treated with LEVEMIR (Unk) (View Levemir Review and Levemir Label ).

6528183-8 | Blood Glucose Abnormal, Respiratory Tract Infection
on Dec 28, 2009 Female patient from UNITED STATES , weighting 162.0 lb, was diagnosed with type 1 diabetes mellitus, prophylaxis, cystic fibrosis, restless legs syndrome, pain management and was treated with Novolog (View Usage). After Novolog was administered, patient had the following side effects: blood glucose abnormal, respiratory tract infection. Novolog dosage: 1u/6carbs If }140 1u/20points. During the same period patient was treated with AZITHROMYCIN (Unk) (View Azithromycin Review and Azithromycin Label ), RIFAMPIN (Unk) (View Rifampin Review and Rifampin Label ), PULMOZYME (Unk) (View Pulmozyme Review and Pulmozyme Label ), ANTIDEPRESSANTS (Unk) (View Antidepressants Review and Antidepressants Label ), NEURONTIN (Unk) (View Neurontin Review and Neurontin Label ), KLONOPIN (Unk) (View Klonopin Review and Klonopin Label ), VITAMIN A (Unk) (View Vitamin A Review and Vitamin A Label ), METHADONE /00068902/ (Unk) (View Methadone /00068902/ Review and Methadone /00068902/ Label ). Patient was hospitalized.

6528182-6 | Accidental Overdose, Blood Glucose Increased, Hypoglycaemia
on Dec 28, 2009 Male patient from UNITED STATES , weighting 173.0 lb, was diagnosed with type 1 diabetes mellitus, hypertension, restless legs syndrome, gastrooesophageal reflux disease, prostatic disorder and was treated with Novolog (View Usage). Patient experienced the following unwanted or unexpected effects: accidental overdose, blood glucose increased, hypoglycaemia. Novolog dosage: Sliding Scale, Prn. During the same period patient was treated with DIOVAN /01319601/ (View Diovan /01319601/ Review and Diovan /01319601/ Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), AVODART (View Avodart Review and Avodart Label ).

6523986-8 | Blood Glucose Increased, Gastrooesophageal Reflux Disease
Patient was taking Novolog (View Usage). Patient had the following side effects: blood glucose increased, gastrooesophageal reflux disease on Dec 21, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 205.0 lb, was diagnosed with insulin-requiring type 2 diabetes mellitus, hypertension, prophylaxis against transplant rejection and. Novolog dosage: Sliding Scale. During the same period patient was treated with NOVOLIN N INNOLET (29 Iu, Qd) (View Novolin N Innolet Review and Novolin N Innolet Label ), ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ). Patient was hospitalized.

6523547-0 | Pneumonia
Adverse event was reported on Dec 22, 2009 by a Female patient taking Novolog (View Usage) (Dosage: Sliding Scale, 2-10 Units With Each Meal) was diagnosed with type 2 diabetes mellitus, autoimmune disorder, atrial fibrillation (What is atrial fibrillation?) and. Location: UNITED STATES , weighting 173.0 lb, After Novolog was administered, patient had the following side effects: pneumonia (What is pneumonia?). During the same period patient was treated with PREDNISOLONE (10 Mg, Qd) (View Prednisolone Review and Prednisolone Label ), CARDIZEM (Unk, Qd) (View Cardizem Review and Cardizem Label ). Patient was hospitalized.

6522275-5 | Agitation, Blood Glucose Decreased, Hyperhidrosis
on Dec 29, 2009 Female patient from UNITED STATES , 34 years of age, was diagnosed with hyperkalaemia and was treated with Novolog (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, blood glucose decreased, hyperhidrosis. Novolog dosage: 10 Units Iv X1.

6522243-3 | Blood Glucose Decreased, Blood Glucose Increased, Convulsion, Incoherent
on Dec 29, 2009 Male patient from UNITED STATES , 68 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Novolog (View Usage). Patient had the following side effects: blood glucose decreased, blood glucose increased, convulsion, incoherent. Novolog dosage: Ssi-m. During the same period patient was treated with NOVOLIN 70/30 (20 Units X 1) (View Novolin 70/30 Review and Novolin 70/30 Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

6517037-9 | Nausea, Oedema Peripheral, Pain
Patient was taking Novolog (View Usage). After Novolog was administered, patient had the following side effects: nausea (What is nausea?), oedema peripheral, pain (What is pain?) on Dec 15, 2009 from UNITED STATES Additional patient health information: Male patient , 61 years of age, was diagnosed with diabetes mellitus, nausea (What is nausea?) and. Novolog dosage: 5 Iu, Tid (after Meals). During the same period patient was treated with LEVEMIR (15 Iu, Qd (at Bedtime)) (View Levemir Review and Levemir Label ), METOCLOPRAMIDE (Unk) (View Metoclopramide Review and Metoclopramide Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), BACLOFEN (Unk) (View Baclofen Review and Baclofen Label ), DOCUSATE (Unk) (View Docusate Review and Docusate Label ). Patient was hospitalized.

6507343-6 | Hypoglycaemia, Sopor
Adverse event was reported on Dec 15, 2009 by a Male patient taking Novolog (View Usage) (Dosage: 41 Iu, Qd) was diagnosed with diabetes mellitus and. Location: ITALY , 57 years of age, Patient experienced the following unwanted or unexpected effects: hypoglycaemia, sopor. During the same period patient was treated with LANTUS (24 Iu, Qd) (View Lantus Review and Lantus Label ), TRIATEC /00116401/ (View Triatec /00116401/ Review and Triatec /00116401/ Label ), REXTAT (View Rextat Review and Rextat Label ), ASPIRIN (100 Mg, Qd) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6505409-8 | Asthenia, Blood Glucose Increased, Body Temperature Increased, Fall, Incorrect Product Storage, Limb Injury, Urinary Tract Infection Pseudomonal
on Dec 11, 2009 Male patient from UNITED STATES , 73 years of age, weighting 250.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Novolog (View Usage). Patient had the following side effects: asthenia, blood glucose increased, body temperature increased, fall (What is fall?), incorrect product storage, limb injury, urinary tract infection pseudomonal. Novolog dosage: Sliding Scale. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

6499063-1 | Cerebrovascular Accident
on Oct 19, 2009 Male patient from UNITED STATES , weighting 193.0 lb, was diagnosed with insulin-requiring type 2 diabetes mellitus, depression (What is depression?), hypertension, cerebrovascular accident, cardiac disorder, sleep disorder (What is sleep disorder?), blood triglycerides increased and was treated with Novolog (View Usage). After Novolog was administered, patient had the following side effects: cerebrovascular accident. Novolog dosage: Unk, Unk. During the same period patient was treated with LANTUS (45 Iu, Bid) (View Lantus Review and Lantus Label ), WELLBUTRIN (300 Mg, Qd) (View Wellbutrin Review and Wellbutrin Label ), COREG (25 Mg, Bid) (View Coreg Review and Coreg Label ), PLAVIX (75 Mg, Qd) (View Plavix Review and Plavix Label ), DIGOXIN (.125 Mg, Qd) (View Digoxin Review and Digoxin Label ), DOXEPIN HCL (25 Mg, Qd) (View Doxepin Hcl Review and Doxepin Hcl Label ), TRICOR (145 Mg, Qd) (View Tricor Review and Tricor Label ), FOLIC ACID (1 Mg, Qd) (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6499062-X | Renal Failure Chronic
Patient was taking Novolog (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure chronic on Oct 19, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 193.0 lb, was diagnosed with insulin-requiring type 2 diabetes mellitus, depression (What is depression?), hypertension, cerebrovascular accident, cardiac disorder, sleep disorder (What is sleep disorder?), blood triglycerides increased and. Novolog dosage: Sliding Scale. During the same period patient was treated with LANTUS (45 Iu, Bid) (View Lantus Review and Lantus Label ), WELLBUTRIN (300 Mg, Qd) (View Wellbutrin Review and Wellbutrin Label ), COREG (25 Mg, Bid) (View Coreg Review and Coreg Label ), PLAVIX (75 Mg, Qd) (View Plavix Review and Plavix Label ), DIGOXIN (.125 Mg, Qd) (View Digoxin Review and Digoxin Label ), DOXEPIN HCL (25 Mg, Qd) (View Doxepin Hcl Review and Doxepin Hcl Label ), TRICOR (145 Mg, Qd) (View Tricor Review and Tricor Label ), FOLIC ACID (1 Mg, Qd) (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6499060-6 | Deafness Unilateral
Adverse event was reported on Oct 19, 2009 by a Male patient taking Novolog (View Usage) (Dosage: Sliding Scale) was diagnosed with insulin-requiring type 2 diabetes mellitus, depression (What is depression?), hypertension, cerebrovascular accident, cardiac disorder, sleep disorder (What is sleep disorder?), blood triglycerides increased and. Location: UNITED STATES , weighting 193.0 lb, Patient had the following side effects: deafness unilateral. During the same period patient was treated with LANTUS (45 Iu, Bid) (View Lantus Review and Lantus Label ), WELLBUTRIN (300 Mg, Qd) (View Wellbutrin Review and Wellbutrin Label ), COREG (25 Mg, Bid) (View Coreg Review and Coreg Label ), PLAVIX (75 Mg, Qd) (View Plavix Review and Plavix Label ), DIGOXIN (.125 Mg, Qd) (View Digoxin Review and Digoxin Label ), DOXEPIN HCL (25 Mg, Qd) (View Doxepin Hcl Review and Doxepin Hcl Label ), TRICOR (145 Mg, Qd) (View Tricor Review and Tricor Label ), FOLIC ACID (1 Mg, Qd) (View Folic Acid Review and Folic Acid Label ).

6499059-X | Intention Tremor
on Oct 19, 2009 Male patient from UNITED STATES , weighting 193.0 lb, was diagnosed with insulin-requiring type 2 diabetes mellitus, depression (What is depression?), hypertension, cerebrovascular accident, cardiac disorder, sleep disorder (What is sleep disorder?), blood triglycerides increased and was treated with Novolog (View Usage). After Novolog was administered, patient had the following side effects: intention tremor. Novolog dosage: Sliding Scale. During the same period patient was treated with LANTUS (45 Iu, Bid) (View Lantus Review and Lantus Label ), WELLBUTRIN (300 Mg, Qd) (View Wellbutrin Review and Wellbutrin Label ), COREG (25 Mg, Bid) (View Coreg Review and Coreg Label ), PLAVIX (75 Mg, Qd) (View Plavix Review and Plavix Label ), DIGOXIN (.125 Mg, Qd) (View Digoxin Review and Digoxin Label ), DOXEPIN HCL (25 Mg, Qd) (View Doxepin Hcl Review and Doxepin Hcl Label ), TRICOR (145 Mg, Qd) (View Tricor Review and Tricor Label ), FOLIC ACID (1 Mg, Qd) (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6499058-8 | Cerebrovascular Accident
on Oct 19, 2009 Male patient from UNITED STATES , weighting 193.0 lb, was diagnosed with insulin-requiring type 2 diabetes mellitus, depression (What is depression?), hypertension, cardiac disorder, sleep disorder (What is sleep disorder?), blood triglycerides increased, cardiac failure congestive and was treated with Novolog (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident. Novolog dosage: Sliding Scale. During the same period patient was treated with LANTUS (45 Iu, Bid) (View Lantus Review and Lantus Label ), WELLBUTRIN (300 Mg, Qd) (View Wellbutrin Review and Wellbutrin Label ), COREG (25 Mg, Bid) (View Coreg Review and Coreg Label ), DIGOXIN (.125 Mg, Qd) (View Digoxin Review and Digoxin Label ), DOXEPIN HCL (25 Mg, Qd) (View Doxepin Hcl Review and Doxepin Hcl Label ), TRICOR (145 Mg, Qd) (View Tricor Review and Tricor Label ), FOLIC ACID (1 Mg, Qd) (View Folic Acid Review and Folic Acid Label ), LASIX (20 Mg, Bid) (View Lasix Review and Lasix Label ). Patient was hospitalized.

6499056-4 | Transient Ischaemic Attack
Patient was taking Novolog (View Usage). Patient had the following side effects: transient ischaemic attack on Oct 19, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 193.0 lb, was diagnosed with insulin-requiring type 2 diabetes mellitus, depression (What is depression?), hypertension, cerebrovascular accident, cardiac disorder, sleep disorder (What is sleep disorder?), blood triglycerides increased and. Novolog dosage: Sliding Scale. During the same period patient was treated with LANTUS (45 Iu, Bid) (View Lantus Review and Lantus Label ), WELLBUTRIN (300 Mg, Qd) (View Wellbutrin Review and Wellbutrin Label ), COREG (25 Mg, Bid) (View Coreg Review and Coreg Label ), PLAVIX (75 Mg, Qd) (View Plavix Review and Plavix Label ), DIGOXIN (.125 Mg, Qd) (View Digoxin Review and Digoxin Label ), DOXEPIN HCL (25 Mg, Qd) (View Doxepin Hcl Review and Doxepin Hcl Label ), TRICOR (145 Mg, Qd) (View Tricor Review and Tricor Label ), FOLIC ACID (1 Mg, Qd) (View Folic Acid Review and Folic Acid Label ).

6499055-2 | Catheter Site Infection
Adverse event was reported on Nov 03, 2009 by a Male patient taking Novolog (View Usage) (Dosage: Sliding Scale) was diagnosed with insulin-requiring type 2 diabetes mellitus, depression (What is depression?), hypertension and. Location: UNITED STATES , weighting 193.0 lb, After Novolog was administered, patient had the following side effects: catheter site infection. During the same period patient was treated with LANTUS (45 Iu, Bid) (View Lantus Review and Lantus Label ), WELLBUTRIN (300 Mg, Qd) (View Wellbutrin Review and Wellbutrin Label ), COREG (25 Mg, Bid) (View Coreg Review and Coreg Label ).

6499026-6 | Diabetic Ketoacidosis
on Oct 17, 2008 Female patient from UNITED STATES , child 9 years of age, weighting 119.9 lb, was diagnosed with type 1 diabetes mellitus and was treated with Novolog (View Usage). Patient experienced the following unwanted or unexpected effects: diabetic ketoacidosis. Novolog dosage: 200 Iu, Q 2 Days, Subcutan.-pump. During the same period patient was treated with ZOLOFT (View Zoloft Review and Zoloft Label ). Patient was hospitalized.

6499025-4 | Blood Glucose Increased
on Oct 08, 2008 Male patient from UNITED STATES , 39 years of age, weighting 224.9 lb, was diagnosed with blood glucose increased and was treated with Novolog (View Usage). Patient had the following side effects: blood glucose increased. Novolog dosage: Subcutaneous. During the same period patient was treated with TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ).

6499020-5 | Device Failure, Diabetic Ketoacidosis, Weight Decreased
Patient was taking Novolog (View Usage). After Novolog was administered, patient had the following side effects: device failure, diabetic ketoacidosis, weight decreased on Oct 30, 2008 from UNITED STATES Additional patient health information: Female patient , 14 years of age, weighting 98.99 lb, was diagnosed with type 1 diabetes mellitus and. Novolog dosage: Subcutaneous. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

6499008-4 | Blood Glucose Increased, Device Failure
Adverse event was reported on Oct 16, 2008 by a Female patient taking Novolog (View Usage) (Dosage: 10 Iu, Qd; 10 Iu, Qd, Subcutaneous; 10 Iu, Qd, Subcutaneous) was diagnosed with type 1 diabetes mellitus and. Location: UNITED STATES , 47 years of age, weighting 110.0 lb, Patient experienced the following unwanted or unexpected effects: blood glucose increased, device failure. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ).

6498971-5 | Hypoglycaemic Unconsciousness
on Oct 08, 2008 Male patient from UNITED STATES , 77 years of age, was diagnosed with insulin-requiring type 2 diabetes mellitus and was treated with Novolog (View Usage). Patient had the following side effects: hypoglycaemic unconsciousness. Novolog dosage: 35 Iu, Qd, Subcutaneous. During the same period patient was treated with LEVEMIR (35 Iu, Qd, Subcutaneous) (View Levemir Review and Levemir Label ).

6498970-3 | Blood Glucose Increased
on Oct 09, 2008 Male patient from UNITED STATES , 27 years of age, weighting 194.0 lb, was diagnosed with type 1 diabetes mellitus and was treated with Novolog (View Usage). After Novolog was administered, patient had the following side effects: blood glucose increased. Novolog dosage: 8-9 Iu/subcutaneous. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), NOVOFINE(R)(NEEDLE) (View Novofine(r)(needle) Review and Novofine(r)(needle) Label ).

6498969-7 | Blood Glucose Increased
Patient was taking Novolog (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased on Nov 04, 2008 from UNITED STATES Additional patient health information: Male patient , 21 years of age, weighting 205.0 lb, was diagnosed with type 1 diabetes mellitus and. Novolog dosage: Sliding Scale, Subcutan.-pump. Patient was hospitalized.

6498961-2 | Blood Glucose Decreased
Adverse event was reported on Dec 08, 2008 by a Female patient taking Novolog (View Usage) (Dosage: 8 Iu, Qd, Subcutaneous; 6 Iu, Subcutaneous) was diagnosed with insulin-requiring type 2 diabetes mellitus and. Location: UNITED STATES , 75 years of age, Patient had the following side effects: blood glucose decreased. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ).

6498953-3 | Hypoglycaemic Unconsciousness
on Dec 15, 2008 Female patient from UNITED STATES , 63 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Novolog (View Usage). After Novolog was administered, patient had the following side effects: hypoglycaemic unconsciousness. Novolog dosage: Tid Based On Diet, Subcutaneous; Tid Based On Diet, Subcutaneous. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), AVAPRO (View Avapro Review and Avapro Label ), CRESTOR (View Crestor Review and Crestor Label ), PROTONIX (View Protonix Review and Protonix Label ).

6498951-X | Anti-insulin Antibody Positive, Blood Glucose Fluctuation, Glycosylated Haemoglobin Increased
on Dec 17, 2008 Male patient from UNITED STATES , child 8 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Novolog (View Usage). Patient experienced the following unwanted or unexpected effects: anti-insulin antibody positive, blood glucose fluctuation, glycosylated haemoglobin increased. Novolog dosage: Subcutaneous. During the same period patient was treated with LANTUS (Subcutaneous) (View Lantus Review and Lantus Label ).

6498949-1 | Blood Glucose Decreased
Patient was taking Novolog (View Usage). Patient had the following side effects: blood glucose decreased on Dec 17, 2008 from UNITED STATES Additional patient health information: Male patient , 55 years of age, was diagnosed with insulin-requiring type 2 diabetes mellitus and. Novolog dosage: Sliding Scale, Prn, Subcutaneous. During the same period patient was treated with LEVEMIR (26 Iu, Qd, Subcutaneous) (View Levemir Review and Levemir Label ). Patient was hospitalized.